Acquisition Begins a Phase of Significant Expansion of Aptuit ’ s API Development Offerings, Including Post-Market Commercial Drug Manufacture. BIOWIRE2K. September 26, ...

Dr. Goldman explained that Aptuit's strategy will allow increased throughput of integrated development programs, as well as deliver standalone API at 40-120 kg batch scale for early to mid-stage ...

CPhI Worlwide, Paris, (Oct. 5)-Following its recently announced acquisition of EaglePicher Pharmaceutical Aptuit, Inc. plans further investment in infrastructure and staff in building its capabilities ...

Greenwich, CT (Sept. 26)––Aptuit, Inc. (Greenwich, CT, www.aptuit.com) agreed to acquire the assets and operations of EaglePicher Pharmaceutical Services (EPPS, Lenexa, KS, www.eaglepicher.com) as ...

A range of services from process development to clinical manufacturing will be proffered. Aptuit secured its first integrated drug delivery contract from Danube Pharmaceuticals. Aptuit will ...

GREENWICH, Connecticut, Jan. 8, 2013 /PRNewswire/ -- Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that Aptuit and Aegerion Pharmaceuticals, Cambridge ...

GREENWICH, Connecticut, April 2, 2015 /PRNewswire/ -- Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has increased its global capacity for Active Pharmaceutical Ingredient (API ...